Medical Device for Treating Fibrous Adhesions
Summary
USPTO granted patent US12588923B2 to Aliform Inc. for a device designed to treat fibrous adhesions such as those implicated in cosmetic conditions including dimpling. The patented device comprises an elongate body with user-controllable breaking means actuatable to move between retracted and operative positions to disrupt fibrous connective tissue. Inventors are Victor Suturin and Mikhail Soutorine.
What changed
USPTO granted patent US12588923B2 to Aliform Inc. for a medical/cosmetic device designed to target and disrupt fibrous adhesions, particularly those implicated in cosmetic conditions like dimpling. The device comprises an elongate body with one or more user-controllable breaking means that move between retracted (collapsed) and operative (expanded) configurations to break strands of fibrous material or connective tissue. The patent application was filed July 10, 2020, under application number 17626306, and contains 12 claims.
This patent grant does not impose compliance obligations on third parties but establishes enforceable intellectual property rights. Competitors developing similar devices for treating fibrous adhesions should review the patent claims for potential infringement concerns and consider licensing discussions with Aliform Inc. if their technology falls within the patent scope. Patent portfolio managers should update IP asset tracking systems with this newly granted patent.
Archived snapshot
Apr 1, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Device for performing a cosmetic or medical procedure
Grant US12588923B2 Kind: B2 Mar 31, 2026
Assignee
Aliform Inc.
Inventors
Victor Suturin, Mikhail Soutorine
Abstract
A device for performing a cosmetic or medical procedure and methods of operating such a device are usable for treating fibrous adhesions, such as those implicated in the formation of cosmetic or medical conditions including but not limited to cellulite. Embodiments of the disclosure have been particularly developed for targeting and disrupting fibrous adhesions to restore or improve normal physiological tissue function and/or aesthetic appearance. In at least one embodiment, the device comprises an elongate body and one or more user controllable breaking means. Each breaking means is actuatable to move between a retracted position in which the breaking means is in a collapsed configuration and an operative position in which the breaking means is in an expanded configuration suitable to break a strand of fibrous material or fibrous connective tissue.
CPC Classifications
A61B 17/32 A61B 2017/00761 A61B 2017/00867 A61B 2017/320044 A61B 2017/00358 A61B 2017/00871 A61B 17/00234 A61B 17/32056 A61B 17/320016 A61B 17/32093 A61B 2017/32006 A61B 17/221 A61B 2017/2212 A61F 2/2442 A61F 2/2445 A61F 2/2448 A61F 2/2451 A61F 2/2463 A61F 2/2466
Filing Date
2020-07-10
Application No.
17626306
Claims
12
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.